These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10206098)

  • 1. Part of prekallikrein removed from human plasma together with IgG--immunoblot experiments and functional tests.
    Briseid K; Hoem NO; Johannesen S
    Scand J Clin Lab Invest; 1999 Feb; 59(1):55-63. PubMed ID: 10206098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
    Briseid K; Lygren I; Johannesen S; Marthinsen K
    Scand J Clin Lab Invest; 2000 May; 60(3):237-45. PubMed ID: 10885496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2002; 62(1):21-4. PubMed ID: 12002409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of IgG for the activity of factor XII measured in human plasma.
    Briseid K; Hoem NO; Johannesen S; Vangen AM; Westgaard T
    Scand J Clin Lab Invest; 1996 Dec; 56(8):725-34. PubMed ID: 9034354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikrein modification with affinity to IgG present in higher amounts than normal in plasma from patients with Crohn's disease.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2003; 63(6):425-9. PubMed ID: 14594323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
    Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
    Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.
    Briseid K; Hoem NO; Johannesen S; Haug K
    Thromb Res; 1995 May; 78(3):239-50. PubMed ID: 7631304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of a variant prekallikrein (PK Zürich).
    Wuillemin WA; Furlan M; von Felten A; Lämmle B
    Thromb Haemost; 1993 Sep; 70(3):427-32. PubMed ID: 8259543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Western blot analyses of prekallikrein and its activation products in human plasma.
    Veloso D; Colman RW
    Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of a prekallikrein concentrate and determination of its activator in blood derivatives].
    Simonianová E
    Cesk Farm; 1992 Feb; 41(1):8-9. PubMed ID: 1586974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact activation factors in plasma from pregnant women--increased level of an association between factor XII and kallikrein.
    Briseid K; Hoem NO; Johannesen S; Fossum S
    Thromb Res; 1991 Jan; 61(2):123-33. PubMed ID: 2020942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autoantibody to human plasma prekallikrein blocks activation of the contact system.
    Page JD; DeLa Cadena RA; Humphries JE; Colman RW
    Br J Haematol; 1994 May; 87(1):81-6. PubMed ID: 7947259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional correlation between kallikrein and factor XII activated in human plasma.
    Briseid K; Hoem NO; Johannesen S; Marthinsen K
    Thromb Res; 1990 Mar; 57(6):945-56. PubMed ID: 1696402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, kinetics, and function of human and rhesus plasma prekallikreins are similar.
    Veloso D; Smith JI; Denny S; Cosgriff TM
    Thromb Haemost; 1992 Nov; 68(5):526-33. PubMed ID: 1455399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
    Lämmle B; Berrettini M; Griffin JH
    Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.